Latest News and Press Releases

PASADENA, CALIF., Feb. 13, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced...

Dublin, Sept. 09, 2024 (GLOBE NEWSWIRE) -- The "Testicular Cancer Drugs - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Testicular...

PASADENA, CA, June 23, 2023 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT) (“LIXTE” or the “Company”) announced today that it has received confirmation from The Nasdaq Stock...

Dublin, Aug. 05, 2022 (GLOBE NEWSWIRE) -- The "Cancer Therapies - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Cancer Therapies Market...

Dublin, Aug. 04, 2022 (GLOBE NEWSWIRE) -- The "RWE Oncology Market by Component, Application, End User - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. The RWE...

Dublin, July 12, 2022 (GLOBE NEWSWIRE) -- The "Global Orphan Cancer Drug Market, Drug Sales, Price & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. ...

PASADENA, CA, April 12, 2022 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage drug discovery company developing pharmacologically active drugs for use in...

SAN FRANCISCO, April 09, 2020 (GLOBE NEWSWIRE) -- Notable, a technology leader redefining cancer treatment through rapid drug development via a clinically validated platform, announced today its...

SAN FRANCISCO, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Notable, which is redefining cancer treatment with a clinically validated platform that rapidly advances cancer drug development at a fraction of the...

SAN FRANCISCO, July 16, 2019 (GLOBE NEWSWIRE) -- Notable, which is redefining cancer treatment with a clinically validated platform that rapidly advances cancer drug development at a fraction of the...